Sanofi News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

15.10.20	Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies (GlobeNewswire)
14.10.20	LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS (RTTNews)
13.10.20	Regeneron: Phase 3 Trial Shows Dupixent Significantly Reduces Severe Asthma Attacks In Children (RTTNews)
13.10.20	Dupixent® (dupilumab) significantly reduced severe asthma attacks in children and is the only biologic to demonstrate improvement in children’s lung function in a randomized Phase 3 trial (GlobeNewswire)
02.10.20	Europe Accepts Sanofi's Regulatory Submission For Enzyme Replacement Therapy For Pompe Disease (RTTNews)
02.10.20	EMA accepts regulatory submission for avalglucosidase alfa, a potentially new standard of care enzyme replacement therapy for Pompe disease (GlobeNewswire)
28.09.20	Sanofi completes Principia Biopharma Inc. acquisition (GlobeNewswire)
25.09.20	Availability of the Q3 2020 Memorandum for modelling purposes (GlobeNewswire)
22.09.20	Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine (GlobeNewswire)
22.09.20	Sanofi - Principia Biopharma Deal Receives U.S. Antitrust Approval (RTTNews)
22.09.20	Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Principia Biopharma Inc. (GlobeNewswire)
21.09.20	Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy increases overall survival in first-line advanced non-small cell lung cancer with PD-L1 expression of =50% (GlobeNewswire)
21.09.20	Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy increases overall survival in first-line advanced non-small cell lung cancer with PD-L1 expression of =50% (GlobeNewswire)
18.09.20	Europe Signs Deal With Sanofi, GSK To Secure Up To 300 Mln COVID-19 Vaccine Doses (RTTNews)
18.09.20	Positive pivotal data for Libtayo® (cemiplimab) monotherapy in locally advanced basal cell carcinoma featured as a late-breaking presentation at ESMO (GlobeNewswire)
18.09.20	Dr. Jean-Christophe Rufin appointed President of the Sanofi Espoir Corporate Foundation (GlobeNewswire)
14.09.20	Regeneron And Sanofi: Dupixent Granted FDA Breakthrough Therapy Designation For EoE (RTTNews)
14.09.20	FDA grants Dupixent® (dupilumab) Breakthrough Therapy designation for eosinophilic esophagitis (GlobeNewswire)
10.09.20	New England Journal of Medicine publishes positive final results from Phase 1/2a study of BIVV001 in people with severe hemophilia A (GlobeNewswire)
08.09.20	Regeneron/Sanofi Reveal Promising Long-term Data Of Dupixent In Moderate-to-severe Asthma (RTTNews)
08.09.20	Dupixent® (dupilumab) long-term data show sustained improvement in lung function and reduction in severe exacerbations in adults and adolescents with moderate-to-severe asthma (GlobeNewswire)
03.09.20	Sanofi, GSK Begin Phase 1/2 Clinical Trial For Adjuvanted COVID-19 Vaccine Candidate - Quick Facts (RTTNews)
03.09.20	Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate (GlobeNewswire)
02.09.20	ATNX To Face FDA In Feb, ICPT Trims Workforce, JNCE Jumps On GILD Deal, SNY's Kevzara Flops Again (RTTNews)
01.09.20	Sanofi Says Kevzara Trial Failed To Meet Endpoints In COVID-19 Patients Outside U.S. (RTTNews)
01.09.20	Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S. (GlobeNewswire)
28.08.20	Sanofi To Commence Tender Offer To Acquire Principia Biopharma (RTTNews)
28.08.20	Sanofi to commence tender offer for acquisition of Principia Biopharma Inc. (GlobeNewswire)
18.08.20	NVAX Begins Vaccine Trial In S.Africa, PSTX Slapped With Clinical Hold, UTHR To Face FDA In Apr. (RTTNews)
17.08.20	Sanofi Agrees To Buy Principia Biopharma In $3.68 Bln Deal - Quick Facts (RTTNews)
17.08.20	Sanofi to acquire Principia Biopharma (GlobeNewswire)
12.08.20	U.S. Reaches Deal With Moderna For 100 Million Doses Of COVID-19 Vaccine (RTTNews)
11.08.20	Perrigo To Acquire Three Eastern European OTC Self-Care Brands From Sanofi - Quick Facts (RTTNews)
03.08.20	Sanofi, GSK In Talks To Supply EU With Up To 300 Mln COVID-19 Vaccine Doses (RTTNews)
31.07.20	Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine (GlobeNewswire)
31.07.20	Sanofi, GSK: COVID-19 Vaccine Candidate Selected By U.S. Government's Operation Warp Speed (RTTNews)
31.07.20	Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine (GlobeNewswire)
30.07.20	Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial (GlobeNewswire)
30.07.20	Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial (GlobeNewswire)
29.07.20	Online availability of Sanofi’s half-year financial report for 2020 (GlobeNewswire)
29.07.20	Sanofi, GSK In Deal With UK Government To Supply Up To 60 Mln Doses Of COVID-19 Vaccine (RTTNews)
29.07.20	Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine (GlobeNewswire)
17.07.20	Sanofi Reportedly Considers Acquisitions Of U.S. Biotechnology Companies (RTTNews)
09.07.20	Kymera Partners With Sanofi To Advance Novel Protein Degrader Therapies (RTTNews)
08.07.20	Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs To Sanofi - Quick Facts (RTTNews)
06.07.20	Availability of the Pre-quarterly Results Communication (GlobeNewswire)
03.07.20	Sanofi, Regeneron Stop Kevzara COVID-19 Trial In U.S. After Failing To Meet Key Goals (RTTNews)
03.07.20	IMMU Continues Ascent, IDXG On Fire, REGN's Kevzara Disappoints In COVID-19 Trial, BLFS On Watch (RTTNews)
02.07.20	Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients (GlobeNewswire)
26.06.20	Sanofi Plans To Cut 1,700 Jobs In Europe (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’059.00	2.92 %	K V
Logitech Intl	94.36	2.03 %	K V
Part Grp Hldg	1’422.50	1.07 %	K V
Sika	242.10	0.71 %	K V
Holcim	98.62	0.39 %	K V
Roche Hldg G	294.50	-1.11 %	K V
Kuehne+Nagel Int	209.20	-1.13 %	K V
Nestle	82.48	-1.43 %	K V
Swisscom	499.80	-2.00 %	K V
Novartis	95.37	-2.46 %	K V

mehr

14.02.25		Angespannte Stimmung in New York: Dow Jones beendet die Sitzung im Minus
14.02.25		Schwache Performance in New York: So bewegt sich der Dow Jones nachmittags
14.02.25		Freitagshandel in New York: Dow Jones liegt mittags im Minus
14.02.25		Börse Zürich: SPI legt zum Handelsende den Rückwärtsgang ein
14.02.25		Handel in London: FTSE 100 zeigt sich letztendlich leichter

14.02.25

Angespannte Stimmung in New York: Dow Jones beendet die Sitzung im Minus

14.02.25

Schwache Performance in New York: So bewegt sich der Dow Jones nachmittags

14.02.25

Freitagshandel in New York: Dow Jones liegt mittags im Minus

14.02.25

Börse Zürich: SPI legt zum Handelsende den Rückwärtsgang ein

14.02.25

Handel in London: FTSE 100 zeigt sich letztendlich leichter